The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crotty, S.
Right arrow Articles by Ahmed, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crotty, S.
Right arrow Articles by Ahmed, R.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Smallpox
The Journal of Immunology, 2003, 171: 4969-4973.
Copyright © 2003 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination 1

Shane Crotty2,*, Phil Felgner{dagger}, Huw Davies3,{ddagger}, John Glidewell*, Luis Villarreal{dagger} and Rafi Ahmed4,*

* Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322; {dagger} Center for Virus Research, University of California, Irvine, CA 92697; and {ddagger} Department of Life Sciences, King’s College, London, United Kingdom

Memory B cells are a central component of humoral immunity, and yet little is known about their longevity in humans. Immune memory after smallpox vaccination (DryVax) is a valuable benchmark for understanding the longevity of B cell memory in the absence of re-exposure to Ag. In this study, we demonstrate that smallpox vaccine-specific memory B cells last for >50 years in immunized individuals. Virus-specific memory B cells initially declined postimmunization, but then reached a plateau ~10-fold lower than peak and were stably maintained for >50 years after vaccination at a frequency of ~0.1% of total circulating IgG+ B cells. These persisting memory B cells were functional and able to mount a robust anamnestic Ab response upon revaccination. Additionally, virus-specific CD4+ T cells were detected decades after vaccination. These data show that immunological memory to DryVax vaccine is long-lived and may contribute to protection against smallpox.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
A. M. Harris, M. S. Bhuiyan, F. Chowdhury, A. I. Khan, A. Hossain, E. A. Kendall, A. Rahman, R. C. LaRocque, J. Wrammert, E. T. Ryan, et al.
Antigen-Specific Memory B-Cell Responses to Vibrio cholerae O1 Infection in Bangladesh
Infect. Immun., September 1, 2009; 77(9): 3850 - 3856.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Bonsignori, M. A. Moody, R. J. Parks, T. M. Holl, G. Kelsoe, C. B. Hicks, N. Vandergrift, G. D. Tomaras, and B. F. Haynes
HIV-1 Envelope Induces Memory B Cell Responses That Correlate with Plasma Antibody Levels after Envelope gp120 Protein Vaccination or HIV-1 Infection
J. Immunol., August 15, 2009; 183(4): 2708 - 2717.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
R. Kennedy, V. S. Pankratz, E. Swanson, D. Watson, H. Golding, and G. A. Poland
Statistical Approach To Estimate Vaccinia-Specific Neutralizing Antibody Titers Using a High-Throughput Assay
Clin. Vaccine Immunol., August 1, 2009; 16(8): 1105 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Guan, M. M. Sajadi, R. Kamin-Lewis, T. R. Fouts, A. Dimitrov, Z. Zhang, R. R. Redfield, A. L. DeVico, R. C. Gallo, and G. K. Lewis
Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection
PNAS, March 10, 2009; 106(10): 3952 - 3957.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. D. Crompton, M. Mircetic, G. Weiss, A. Baughman, C.-Y. Huang, D. J. Topham, J. J. Treanor, I. Sanz, F. E.-H. Lee, A. P. Durbin, et al.
The TLR9 Ligand CpG Promotes the Acquisition of Plasmodium falciparum-Specific Memory B Cells in Malaria-Naive Individuals
J. Immunol., March 1, 2009; 182(5): 3318 - 3326.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. R.-E.-I. Benhnia, M. M. McCausland, J. Moyron, J. Laudenslager, S. Granger, S. Rickert, L. Koriazova, R. Kubo, S. Kato, and S. Crotty
Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on Complement
J. Virol., February 1, 2009; 83(3): 1201 - 1215.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. G. Barbour, A. Jasinskas, M. A. Kayala, D. H. Davies, A. C. Steere, P. Baldi, and P. L. Felgner
A Genome-Wide Proteome Array Reveals a Limited Set of Immunogens in Natural Infections of Humans and White-Footed Mice with Borrelia burgdorferi
Infect. Immun., August 1, 2008; 76(8): 3374 - 3389.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Richard, S. K. Pierce, and W. Song
The Agonists of TLR4 and 9 Are Sufficient to Activate Memory B Cells to Differentiate into Plasma Cells In Vitro but Not In Vivo
J. Immunol., August 1, 2008; 181(3): 1746 - 1752.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Jing, D. H. Davies, T. M. Chong, S. Chun, C. L. McClurkan, J. Huang, B. T. Story, D. M. Molina, S. Hirst, P. L. Felgner, et al.
An Extremely Diverse CD4 Response to Vaccinia Virus in Humans Is Revealed by Proteome-Wide T-Cell Profiling
J. Virol., July 15, 2008; 82(14): 7120 - 7134.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. A. Huff and W. Matsui
Multiple Myeloma Cancer Stem Cells
J. Clin. Oncol., June 10, 2008; 26(17): 2895 - 2900.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Mamani-Matsuda, A. Cosma, S. Weller, A. Faili, C. Staib, L. Garcon, O. Hermine, O. Beyne-Rauzy, C. Fieschi, J.-O. Pers, et al.
The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells
Blood, May 1, 2008; 111(9): 4653 - 4659.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R.-H. Xu, M. Cohen, Y. Tang, E. Lazear, J. C. Whitbeck, R. J. Eisenberg, G. H. Cohen, and L. J. Sigal
The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination
J. Exp. Med., April 14, 2008; 205(4): 981 - 992.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. R.-E.-I. Benhnia, M. M. McCausland, H.-P. Su, K. Singh, J. Hoffmann, D. H. Davies, P. L. Felgner, S. Head, A. Sette, D. N. Garboczi, et al.
Redundancy and Plasticity of Neutralizing Antibody Responses Are Cornerstone Attributes of the Human Immune Response to the Smallpox Vaccine
J. Virol., April 1, 2008; 82(7): 3751 - 3768.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. B. Rohner, M. D. Snape, D. F. Kelly, T. John, A. Morant, L.-M. Yu, A. Borkowski, F. Ceddia, R. Borrow, C.-A. Siegrist, et al.
The Magnitude of the Antibody and Memory B Cell Responses during Priming with a Protein-Polysaccharide Conjugate Vaccine in Human Infants Is Associated with the Persistence of Antibody and the Intensity of Booster Response
J. Immunol., February 15, 2008; 180(4): 2165 - 2173.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Matsui, Q. Wang, J. P. Barber, S. Brennan, B. D. Smith, I. Borrello, I. McNiece, L. Lin, R. F. Ambinder, C. Peacock, et al.
Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance
Cancer Res., January 1, 2008; 68(1): 190 - 197.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Bhattacharya, M. T. Cheah, C. B. Franco, N. Hosen, C. L. Pin, W. C. Sha, and I. L. Weissman
Transcriptional Profiling of Antigen-Dependent Murine B Cell Differentiation and Memory Formation
J. Immunol., November 15, 2007; 179(10): 6808 - 6819.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
I. J. Amanna, N. E. Carlson, and M. K. Slifka
Duration of Humoral Immunity to Common Viral and Vaccine Antigens
N. Engl. J. Med., November 8, 2007; 357(19): 1903 - 1915.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
K. L. Karem, M. Reynolds, C. Hughes, Z. Braden, P. Nigam, S. Crotty, J. Glidewell, R. Ahmed, R. Amara, and I. K. Damon
Monkeypox-Induced Immunity and Failure of Childhood Smallpox Vaccination To Provide Complete Protection
Clin. Vaccine Immunol., October 1, 2007; 14(10): 1318 - 1327.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. P. Perera, T. A. Waldmann, J. D. Mosca, N. Baldwin, J. A. Berzofsky, and S.-K. Oh
Development of Smallpox Vaccine Candidates with Integrated Interleukin-15 That Demonstrate Superior Immunogenicity, Efficacy, and Safety in Mice
J. Virol., August 15, 2007; 81(16): 8774 - 8783.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
A. D. Garcia, C. A. Meseda, A. E. Mayer, A. Kumar, M. Merchlinsky, and J. P. Weir
Characterization and Use of Mammalian-Expressed Vaccinia Virus Extracellular Membrane Proteins for Quantification of the Humoral Immune Response to Smallpox Vaccines
Clin. Vaccine Immunol., August 1, 2007; 14(8): 1032 - 1044.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Mitra-Kaushik, J. Cruz, L. J. Stern, F. A. Ennis, and M. Terajima
Human Cytotoxic CD4+ T Cells Recognize HLA-DR1-Restricted Epitopes on Vaccinia Virus Proteins A24R and D1R Conserved among Poxviruses
J. Immunol., July 15, 2007; 179(2): 1303 - 1312.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
S. Sundaresh, A. Randall, B. Unal, J. M. Petersen, J. T. Belisle, M. Gill Hartley, M. Duffield, R. W. Titball, D. H. Davies, P. L. Felgner, et al.
From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis
Bioinformatics, July 1, 2007; 23(13): i508 - i518.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Moutaftsi, H.-H. Bui, B. Peters, J. Sidney, S. Salek-Ardakani, C. Oseroff, V. Pasquetto, S. Crotty, M. Croft, E. J. Lefkowitz, et al.
Vaccinia Virus-Specific CD4+ T Cell Responses Target a Set of Antigens Largely Distinct from Those Targeted by CD8+ T Cell Responses
J. Immunol., June 1, 2007; 178(11): 6814 - 6820.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Jing, T. M. Chong, B. Byrd, C. L. McClurkan, J. Huang, B. T. Story, K. M. Dunkley, L. Aldaz-Carroll, R. J. Eisenberg, G. H. Cohen, et al.
Dominance and Diversity in the Primary Human CD4 T Cell Response to Replication-Competent Vaccinia Virus
J. Immunol., May 15, 2007; 178(10): 6374 - 6386.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Dasgupta, E. Hammarlund, M. K. Slifka, and K. Fruh
Cowpox Virus Evades CTL Recognition and Inhibits the Intracellular Transport of MHC Class I Molecules
J. Immunol., February 1, 2007; 178(3): 1654 - 1661.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Gatto, S. W. Martin, J. Bessa, E. Pellicioli, P. Saudan, H. J. Hinton, and M. F. Bachmann
Regulation of Memory Antibody Levels: The Role of Persisting Antigen versus Plasma Cell Life Span
J. Immunol., January 1, 2007; 178(1): 67 - 76.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. F. Kelly, M. D. Snape, E. A. Cutterbuck, S. Green, C. Snowden, L. Diggle, L.-m. Yu, A. Borkowski, E. R. Moxon, and A. J. Pollard
CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells
Blood, October 15, 2006; 108(8): 2642 - 2647.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. J. Zaunders, W. B. Dyer, M. L. Munier, S. Ip, J. Liu, E. Amyes, W. Rawlinson, R. De Rose, S. J. Kent, J. S. Sullivan, et al.
CD127+CCR5+CD38+++ CD4+ Th1 Effector Cells Are an Early Component of the Primary Immune Response to Vaccinia Virus and Precede Development of Interleukin-2+ Memory CD4+ T Cells.
J. Virol., October 1, 2006; 80(20): 10151 - 10161.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Chahroudi, D. A. Garber, P. Reeves, L. Liu, D. Kalman, and M. B. Feinberg
Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus ankara and vaccinia virus.
J. Virol., September 1, 2006; 80(17): 8469 - 8481.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. Panchanathan, G. Chaudhri, and G. Karupiah
Protective Immunity against Secondary Poxvirus Infection Is Dependent on Antibody but Not on CD4 or CD8 T-Cell Function.
J. Virol., July 1, 2006; 80(13): 6333 - 6338.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Chaudhri, V. Panchanathan, H. Bluethmann, and G. Karupiah
Obligatory requirement for antibody in recovery from a primary poxvirus infection.
J. Virol., July 1, 2006; 80(13): 6339 - 6344.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
N. Jacobs, R. A.-J. Chen, C. Gubser, P. Najarro, and G. L. Smith
Intradermal immune response after infection with Vaccinia virus.
J. Gen. Virol., May 1, 2006; 87(Pt 5): 1157 - 1161.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. P. Chappell and J. Jacob
Identification of memory B cells using a novel transgenic mouse model.
J. Immunol., April 15, 2006; 176(8): 4706 - 4715.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
J. Rinaggio and M. Glick
The smallpox vaccine: An update for oral health care professionals
J Am Dent Assoc, April 1, 2006; 137(4): 452 - 460.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. D. Genova, J. Roddick, F. McNicholl, and F. K. Stevenson
Vaccination of human subjects expands both specific and bystander memory T cells but antibody production remains vaccine specific
Blood, April 1, 2006; 107(7): 2806 - 2813.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. F. Kelly, A. J. Pollard, and E. R. Moxon
Immunological Memory: The Role of B Cells in Long-term Protection Against Invasive Bacterial Pathogens
JAMA, December 21, 2005; 294(23): 3019 - 3023.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. M. Putz, I. Alberini, C. M. Midgley, I. Manini, E. Montomoli, and G. L. Smith
Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy
J. Gen. Virol., November 1, 2005; 86(11): 2955 - 2960.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. H. Davies, M. M. McCausland, C. Valdez, D. Huynh, J. E. Hernandez, Y. Mu, S. Hirst, L. Villarreal, P. L. Felgner, and S. Crotty
Vaccinia Virus H3L Envelope Protein Is a Major Target of Neutralizing Antibodies in Humans and Elicits Protection against Lethal Challenge in Mice
J. Virol., September 15, 2005; 79(18): 11724 - 11733.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Panchanathan, G. Chaudhri, and G. Karupiah
Interferon function is not required for recovery from a secondary poxvirus infection
PNAS, September 6, 2005; 102(36): 12921 - 12926.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. S. Jackson, P. Ilyinskii, V. Philippon, L. Gritz, A. G. Yafal, K. Zinnack, K. R. Beaudry, K. H. Manson, M. A. Lifton, M. J. Kuroda, et al.
Role of Genes That Modulate Host Immune Responses in the Immunogenicity and Pathogenicity of Vaccinia Virus
J. Virol., May 15, 2005; 79(10): 6554 - 6559.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
S. Hatakeyama, K. Moriya, M. Saijo, Y. Morisawa, I. Kurane, K. Koike, S. Kimura, and S. Morikawa
Persisting Humoral Antiviral Immunity within the Japanese Population after the Discontinuation in 1976 of Routine Smallpox Vaccinations
Clin. Vaccine Immunol., April 1, 2005; 12(4): 520 - 524.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. H. Davies, X. Liang, J. E. Hernandez, A. Randall, S. Hirst, Y. Mu, K. M. Romero, T. T. Nguyen, M. Kalantari-Dehaghi, S. Crotty, et al.
Profiling the humoral immune response to infection by using proteome microarrays: High-throughput vaccine and diagnostic antigen discovery
PNAS, January 18, 2005; 102(3): 547 - 552.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. C. Jaimes, O. L. Rojas, E. J. Kunkel, N. H. Lazarus, D. Soler, E. C. Butcher, D. Bass, J. Angel, M. A. Franco, and H. B. Greenberg
Maturation and Trafficking Markers on Rotavirus-Specific B Cells during Acute Infection and Convalescence in Children
J. Virol., October 15, 2004; 78(20): 10967 - 10976.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. J. Wherry and R. Ahmed
Memory CD8 T-Cell Differentiation during Viral Infection
J. Virol., June 1, 2004; 78(11): 5535 - 5545.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.